Product Images Olmesartan Medoxomil And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Olmesartan Medoxomil And Hydrochlorothiazide NDC 46708-150 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - olmesartanhctz hctz

Structure - olmesartanhctz hctz

30's bottle pack - olmesartanhctz mg20125

30's bottle pack - olmesartanhctz mg20125

Each coated tablet of this medication contains 20mg of Fomssatn and Nedoram, as well as Olmesartan Medoxomil and Hydrochlorothiazide. The dosage and usage guidance for this medication can be found in the package insert and it should be stored at USP Controlled Room Temperature. It contains 30 tablets. The manufacturer is N Ramraics Intad and this product is available only by prescription. The location of the manufacturer is in India.*

30's bottle pack - olmesartanhctz mg40125

30's bottle pack - olmesartanhctz mg40125

Each film-coated tablet contains 40mg of olmesartan medoxomil and hydrochlorothiazide. It is manufactured and distributed in the United States by Promasetics, and is available by prescription only. The tablets should be stored at room temperature between 20 to 25°C (68 to 77°F). The NDC code for this medication is 46708-150-30, and each package contains 20 tablets. Dosage instructions are not available.*

30's bottle pack - olmesartanhctz mg4025

30's bottle pack - olmesartanhctz mg4025

Structure - olmesartanhctz olme

Structure - olmesartanhctz olme

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.